Genpharmasec Limited (BOM:531592)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceuticals	1.31B	325.56M	304.06M	252.83M	266.11M
Pharmaceuticals Growth	301.99%	7.07%	20.26%	-4.99%	27.94%
Manufacturing & Processing	80.62M	-	-	-	-
Laboratory Testing	10.05M	11.63M	-	-	-
Laboratory Testing Growth	-13.63%	-	-	-	-
Trading in Securities	-	30.00K	-	2.32M	7.09M
Trading in Securities Growth	-	-	-	-67.25%	39.57%
Total	1.40B	337.22M	304.06M	255.16M	273.21M
Total Growth	314.98%	10.91%	19.16%	-6.61%	28.22%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	1.40B	337.22M	304.06M	255.16M	273.21M
India Growth	314.98%	10.91%	19.16%	-6.61%	28.22%
Total	1.40B	337.22M	304.06M	255.16M	273.21M
Total Growth	314.98%	10.91%	19.16%	-6.61%	28.22%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error